Literature DB >> 28538871

What do Cochrane systematic reviews say about interventions for autism spectrum disorders?

Larissa Lyra1, Luiz Eduardo Rizzo1, Camila Sá Sunahara1, Daniela Vianna Pachito2, Carolina de Oliveira Cruz Latorraca3, Ana Luiza Cabrera Martimbianco4, Rachel Riera5.   

Abstract

CONTEXT AND
OBJECTIVE: : Autism spectrum disorders (ASDs) include autistic disorder, Asperger's disorder and pervasive developmental disorder. The manifestations of ASDs can have an important impact on learning and social functioning that may persist during adulthood. The aim here was to summarize the evidence from Cochrane systematic reviews on interventions for ASDs. DESIGN AND
SETTING: : Review of systematic reviews, conducted within the Discipline of Evidence-Based Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo.
METHODS: : We included and summarized the results from Cochrane systematic reviews on interventions for ASDs.
RESULTS: : Seventeen reviews were included. These found weak evidence of benefits from acupuncture, gluten and casein-free diets, early intensive behavioral interventions, music therapy, parent-mediated early interventions, social skill groups, Theory of Mind cognitive model, aripiprazole, risperidone, tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRI); this last only for adults. No benefits were found for sound therapies, chelating agents, hyperbaric oxygen therapy, omega-3, secretin, vitamin B6/magnesium and SSRI for children.
CONCLUSION: : Acupuncture, gluten and casein-free diets, early intensive behavioral interventions, music therapy, parent-mediated early interventions, social skill groups and the Theory of Mind cognitive model seem to have benefits for patients with autism spectrum disorders (very low to low-quality evidence). Aripiprazole, risperidone, tricyclic antidepressants and SSRI (this last only for adults) also showed some benefits, although associated with higher risk of adverse events. Experimental studies to confirm a link between probable therapies and the disease, and then high-quality long-term clinical trials, are needed.

Entities:  

Mesh:

Year:  2017        PMID: 28538871     DOI: 10.1590/1516-3180.2017.0058200317

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  6 in total

Review 1.  Post-diagnostic management and follow-up care for autism spectrum disorder.

Authors:  Angie Ip; Lonnie Zwaigenbaum; Jessica A Brian
Journal:  Paediatr Child Health       Date:  2019-10-24       Impact factor: 2.253

2.  The Treatment of Autism Spectrum Disorder With Auditory Neurofeedback: A Randomized Placebo Controlled Trial Using the Mente Autism Device.

Authors:  Frederick R Carrick; Guido Pagnacco; Ahmed Hankir; Mahera Abdulrahman; Rashid Zaman; Emily R Kalambaheti; Derek A Barton; Paul E Link; Elena Oggero
Journal:  Front Neurol       Date:  2018-07-05       Impact factor: 4.003

3.  Music and Sound-Based Intervention in Autism Spectrum Disorder: A Scoping Review.

Authors:  Fatin Amira Shahrudin; Ahmad Aidil Arafat Dzulkarnain; Ayu Madiha Hanafi; Fatin Nabilah Jamal; Nadzirah Ahmad Basri; Shahrul Na'im Sidek; Hazlina Md Yusof; Madihah Khalid
Journal:  Psychiatry Investig       Date:  2022-08-24       Impact factor: 3.202

4.  Feasibility of a best-worst scaling exercise to set priorities for autism research.

Authors:  Scott A Davis; Kirsten Howard; Alan R Ellis; Daniel E Jonas; Timothy S Carey; Joseph P Morrissey; Kathleen C Thomas
Journal:  Health Expect       Date:  2022-06-08       Impact factor: 3.318

Review 5.  Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: A possible role of fluoride and aluminum.

Authors:  Anna Strunecka; Russell L Blaylock; Jiri Patocka; Otakar Strunecky
Journal:  Surg Neurol Int       Date:  2018-04-09

Review 6.  The Potential Role of Gut Peptide Hormones in Autism Spectrum Disorder.

Authors:  Xin-Rui Qi; Li Zhang
Journal:  Front Cell Neurosci       Date:  2020-03-31       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.